Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Mylan .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2019 | Mylan | Health | Mylan has a long-standing commitment to addressing unmet patient needs and leading the way when it comes to industry change. That’s why Mylan works in good faith with various stakeholders and uses strong alliances with… (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Mylan | Health | Mylan welcoming pioneering HSE's new HIV Prevention Programme etc. (Public policy or programme) | 285 | On lobbying.ie |
| Sep–Dec 2019 | Mylan | Health | EU Pharmaceuticals in the Environment (PiE) Directive and related matters. (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2019 | Mylan | Health | Healthcare policy developments in Ireland and Brussels (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2017 | Mylan | Health | The Department of Health must develop and implement a National Biosimilars Policy, whose objective is to significantly increase the usage of biosimilars in Ireland . This policy must include: • Legislation which reforms… (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2017 | Mylan | Health | To increase awareness around Ireland's sub standard public policy environment which is limiting the availability of biosimilar medicines in Ireland. (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Mylan | Health | Outlined a number of key Healthcare Enterprise Alliance policy proposals which have the potential to save the HSE, €100+ Million. Including; switching prescribing from biologics to equivalent biosimilar medicines… (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 100.0% |